Please check your internet connection and try again.
# Ezivac enema
## Overview
Ezivac enema is a sodium phosphate solution used as a hyperosmotic laxative for evacuation of the bowel.
## Primary Indications
* Constipation
* Bowel preparation prior to medical procedures (e.g., colonoscopy, sigmoidoscopy) or surgery.
## Adult Dosing
* **Constipation:** Typically, one enema (4.5 oz or 133 mL) is administered as a single dose. Maximum frequency not well-established, but typically limited to occasional use.
* **Bowel Preparation:** One enema (4.5 oz or 133 mL) administered as directed by the prescriber, usually once or twice depending on the procedure.
## Pediatric Dosing
* **Constipation/Bowel Preparation:** Use is generally not recommended in children under 5 years of age due to increased risk of adverse effects. For children 5 years and older, dosing should be based on prescriber recommendation and may require a reduced volume. Consult specific pediatric guidelines or prescriber.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised due to electrolyte shifts.
## Contraindications
* Congenital or acquired megacolon.
* Bowels obstructions.
* Heart failure.
* Children under 5 years of age.
* Patients with impaired kidney function.
* Patients with increased risk of electrolyte imbalance (e.g., those on diuretic therapy, elderly, patients with renal insufficiency).
* Patients with active inflammatory bowel disease.
* Acute appendicitis symptoms.
## Adverse Effects
* **Common:** Abdominal cramping, bloating, nausea, diarrhea, rectal irritation.
* **Serious:** Hyperphosphatemia, hypocalcemia, hypernatremia, dehydration, renal damage (acute tubular necrosis), cardiac arrhythmias, seizures. These are more likely with overuse, rapid administration, or in susceptible individuals.
## Key Drug Interactions
* **Diuretics:** Increased risk of dehydration and electrolyte imbalances.
* **ACE inhibitors/ARBs:** Increased risk of hyperkalemia.
* **Lithium:** Decreased lithium levels due to altered absorption/excretion.
* **Other laxatives:** Use with caution to avoid excessive bowel stimulation and electrolyte disturbances.
## Monitoring
* Monitor for signs of dehydration (thirst, dry mouth, decreased urine output).
* Monitor for electrolyte abnormalities (sodium, potassium, phosphate, calcium) especially in patients with risk factors or with frequent/excessive use.
* Assess bowel movements for effectiveness and any signs of rectal irritation.
## Clinical Pearls
* Administer slowly and retain the enema for the recommended duration (typically 5-15 minutes) to ensure efficacy and minimize cramping.
* Avoid use in patients with any contraindications.
* This product should not be used for chronic constipation.
* Educate patients on proper administration technique and potential adverse effects.
* Ensure adequate fluid intake.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant medical literature for complete details and to verify dosing and safety before patient administration.
